Ultragenyx Pharmaceutical Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
RARE on Nasdaq
Industry
Pharmaceutical Preparations
Location
60 Leveroni Court, Novato, California

Insiders trading volume in the past year

Ultragenyx Pharmaceutical Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Emil D. Kakkis President & CEO, Director $152 M -$4.39 M -2.81% Mar 1, 2024
Thomas Richard Kassberg Cbo & Evp $12.6 M -$1.94 M -13.3% Mar 11, 2024
Howard Horn Chief Financial Officer $5.36 M Mar 1, 2024
John Richard Pinion EVP, Chief Quality Operations Officer $4.8 M -$224 K -4.47% Mar 1, 2024
Dennis Karl Huang EVP, Chief Technical Operations Officer $4.46 M Mar 1, 2024
Erik Harris EVP & Chief Commercial Officer $3.61 M -$484 K -11.8% Mar 1, 2024
Karah Parschauer EVP and Chief Legal Officer $2.61 M -$643 K -19.8% Jun 12, 2024
Eric Crombez EVP and Chief Medical Officer $2.11 M -$88.3 K -4.01% May 2, 2024
Theodore Alan Huizenga SVP, Chief Accounting Officer $1.75 M -$143 K -7.53% Apr 16, 2024
William Aliski Director $1.62 M Jun 24, 2021
Mardi Dier CFO & Executive Vice President $1.4 M Oct 14, 2022
Daniel G. Welch Director $1.21 M Jun 18, 2024
Michael Narachi Director $1.21 M Jun 18, 2024
Deborah Dunsire Director $1.13 M Jun 18, 2024
Camille L. Bedrosian EVP and Chief Medical Officer $981 K Mar 1, 2023
Matthew K. Fust Director $909 K -$620 K -40.6% Jun 18, 2024
Shehnaaz Suliman Director $909 K Jun 18, 2024
Amrit Ray Director $793 K Jun 18, 2024
(Corsee) Sanders Corazon Director $492 K -$95.3 K -16.2% Jul 2, 2024
Lars Ekman Director $373 K Jun 24, 2022

Recent Insider Transactions by Companies or Individuals for Ultragenyx Pharmaceutical Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership